The Centre for Innovation in Practice is part of
the School of Pharmacy and Pharmaceutical Sciences
Centre for Innovation in Practice

CIP conference abstracts

2010

 

Conducting a realist review of a complex concept in the pharmacy practice literature: methodological issues. Jacobs S, Ashcroft D, Hassell K. International Journal of Pharmacy Practice 2009; 18 (suppl 1): 2. Presented at the Health Services Research & Pharmacy Practice Conference, University of Manchester, 12-13th April 2010.
Using social network analysis to study integration between general practitioners and community pharmacists: a novel application. Bradley F, Ashcroft DM, Crossley N. International Journal of Pharmacy Practice 2009; 18 (suppl 1): 4. Presented at the Health Services Research & Pharmacy Practice Conference, University of Manchester, 12-13th April 2010.
Learning professionalism in the MPharm – what role does “organisational philosophy” play? Schafheutle EI, Hassell K, Ashcroft DM, Hall J, Harrison S. International Journal of Pharmacy Practice 2009; 18 (suppl 1): 25. Presented at the Health Services Research & Pharmacy Practice Conference, University of Manchester, 12-13th April 2010.
The impact of professional culture on prescribing safety. Lewis PJ, Ashcroft DM, Dornan T, Taylor D, Wass V, Tully MP. International Journal of Pharmacy Practice 2009; 18 (suppl 1): 29. Presented at the Health Services Research & Pharmacy Practice Conference, University of Manchester, 12-13th April 2010.
Are there geographical variations in uptake of the Scottish Minor Ailments Scheme? Wagner AC, Noyce PR, Ashcroft DM. International Journal of Pharmacy Practice 2009; 18 (suppl 1): 42. Presented at the Health Services Research & Pharmacy Practice Conference, University of Manchester, 12-13th April 2010.
What are the key features of the community pharmacy work system?  Phipps DL, Ashcroft DM. International Journal of Pharmacy Practice 2009; 18 (suppl 1): 55. Presented at the Health Services Research & Pharmacy Practice Conference, University of Manchester, 12-13th April 2010.
Aspects of organisational culture in community pharmacies: findings from  a literature review. Jacobs S, Ashcroft D, Hassell K. 7th Biennial International Conference in Organisational Behaviour in Health Care, University of Birmingham, 11-14th April 2010.
Targets, markets and the social order: the gap between theory and practice in English community pharmacy policy. McDonald R, Cheraghi-Sohi S, Sanders C, Ashcroft D. 7th Biennial International Conference in Organisational Behaviour in Health Care, University of Birmingham, 11-14th April 2010.
Influence of general practice size on quality and outcomes framework coronary heart disease prescribing indicators: 2005-2009. Wagner A.

Drug Utilisation Research Group, 21st Annual Scientific Meeting, London, 4th February 2010.

2009

 

Medicines reconciliation: developing quality indicators. PC-12. Al-Jamal M, Ashcroft DM, Tully MP.

8th European Symposium on Clinical Pharmacy. Switzerland: Geneva, 3-6th Nov 2009.

Development and face-validity of explicit indicators for access to community pharmacy services: a Delphi consultation study. D. Halsall, D. Ashcroft and P. Noyce

26th Conference of the International Society for Quality in Health Care (ISQUa). Ireland: Dublin, 11-14th Oct 2009.

Developing quality indicators for community pharmacy premises: a Delphi consultation study D. Halsall, D. Ashcroft and P. Noyce

British Pharmaceutical Conference, Manchester. International Journal of Pharmacy Practice September 2009; Suppl 2, B84

Developing quality indicators for community pharmacy. Ashcroft DM Invited presentation, British Pharmaceutical Conference. Manchester: Manchester Central Convention Complex, 6th September 2009
Quality and patient safety: implications for medicines management and pharmacy practice. Pharmacy Practice Research Trust Award Lecture Ashcroft DM Invited presentation, British Pharmaceutical Conference. Manchester: Manchester Central Convention Complex, 7th September 2009
Prevalence, nature and severity of prescribing errors in hospital inpatients: Prospective study in 20 UK hospitals. Ashcroft DM, Lewis PJ, Carter E, Taylor D, Tully MP, Wass V, Williams S, Dornan T. Pharmacoepidemiology and Drug Safety 2009; 18(1): S120. 25th International Conference on Pharmacoepidemiology and Risk Management, Rhode Island Convention Center, Providence, Rhode Island, USA Aug 16-19, 2009
Prevalence, clinical profile and preventability of drug-related hospital admissions: prospective observational study. Ashcroft DM, Kongkaew C, Williams S, Metcalfe D, Mandal J, Noyce P. Pharmacoepidemiology and Drug Safety 2009; 18(1): S121. 25th International Conference on Pharmacoepidemiology and Risk Management, Rhode Island Convention Center, Providence, Rhode Island, USA Aug 16-19, 2009
Improvements in quality of life and functional status in patients with psoriatic arthritis: Analysis of the BSR Biologics Register. Pharmacoepidemiology and Drug Safety . Saad AA, Ashcroft DM, Watson KD, Symmons DP, Hyrich KL Pharmacoepidemiology and Drug Safety 2009; 18(1): S258. 25th International Conference on Pharmacoepidemiology and Risk Management, Rhode Island Convention Center, Providence, Rhode Island, USA Aug 16-19, 2009
Organisational culture as a mediator of quality in community pharmacy practice – does it have a role? Jacobs S, Ashcroft, DM, Hassell K Health Services Research and Pharmacy Practice Conference, 30-31 March 2009. International Journal of Pharmacy Practice 2009; 17 (suppl 1): A30.
The culture of safety: results from a cross-sectional survey of 998 community pharmacists. Ashcroft DM, Parker D. American College of Clinical Pharmacy (ACCP) and the European Society for Clinical Pharmacy (ESCP) International Congress. Florida: Orlando, 24-28th April 2009. External link
Drug-related hospital admissions: prospective analysis of 3904 patients. Kongkaew C, Noyce P, Williams S, Metcalfe D, Mandal J, Ashcroft DM. American College of Clinical Pharmacy (ACCP) and the European Society for Clinical Pharmacy (ESCP) International Congress. Florida: Orlando, 24-28th April 2009. External link
Examining patient safety climate in the hospital pharmacy setting: a cross-sectional survey. Williams SD, Ashcroft DM. American College of Clinical Pharmacy (ACCP) and the European Society for Clinical Pharmacy (ESCP) International Congress. Florida: Orlando, 24-28th April 2009. External link
Attitudes of hospital pharmacists to reporting medication errors: insights from focus groups. Williams SD, Ashcroft DM. American College of Clinical Pharmacy (ACCP) and the European Society for Clinical Pharmacy (ESCP) International Congress. Florida: Orlando, 24-28th April 2009. External link

2008

 

Framework for understanding quality in the community pharmacy setting. Halsall D, Noyce P, Ashcroft D. 43rd American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Florida: Orlando, 7-11 December 2008
Errors and violations in community pharmacies: a focus group study. Ashcroft DM, Parker D, Noyce P. 43rd American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Florida: Orlando, 7-11 December 2008
Understanding safety climate in community pharmacies: cross-sectional study in the UK. Ashcroft DM, Parker D. 43rd American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Florida: Orlando, 7-11 December 2008
Patient safety in the community pharmacy setting: insights from Human Error Theory Ashcroft DM, Parker D, Morecroft C, Noyce PR 25th Conference of the International Society for Quality in Health Care (ISQUa). Denmark: Copenhagen, 19-22nd Oct 2008
Safety climate in community pharmacies: Exploring the impact of demographic and organisational factors Ashcroft DM, Parker D 25th Conference of the International Society for Quality in Health Care (ISQUa). Denmark: Copenhagen, 19-22nd Oct 2008
Practical experience with biologic drug therapies for the treatment of psoriasis in a UK tertiary referral centre Brown BC, Warren RB, Lavery D, Ashcroft DM, Griffiths CEM 17th European Academy of Dermatology Venereology Annual Congress. France: Paris, FP1459
What is quality in the community pharmacy setting? Development of a conceptual framework Halsall D, Ashcroft DM, Noyce PR British Pharameutical Conference, Manchester, 7-9 September 2008. International Journal of Pharmacy Practice 2008; 16 (suppl 3): C17-C18.
Patient safety in pharmacy education: what is the role of the hidden curriculum? Bradley F, Steven A, Dagley V, Ashcroft DM British Pharameutical Conference, Manchester, 7-9 September 2008. International Journal of Pharmacy Practice 2008; 16 (suppl 3): C29-C30. External link
A systematic review of the causes of and factors associated with prescribing errors. Tully MP, Lewis PJ, Ashcroft D, Taylor D, Wass V, Dornan T. British Pharameutical Conference, Manchester, 7-9 September 2008. International Journal of Pharmacy Practice 2008; 16 (suppl 3): C58-C59. External link
Job satisfaction of pharmacists: a critical appraisal of existing tools. Ferguson J, Hassell K, Ashcroft DM. British Pharameutical Conference, Manchester, 7-9 September 2008. International Journal of Pharmacy Practice 2008; 16 (suppl 3): C44-C45. External link
Examining patient safety climate in the hospital pharmacy setting: a cross-sectional survey/strong Williams SD, Ashcroft DM British Pharameutical Conference, Manchester, 7-9 September 2008. International Journal of Pharmacy Practice 2008; 16 (suppl 3): C43-C44. External link
Drug persistence on anti-TNF-α agents in psoriatic arthritis. Saad AA, Ashcroft DM, Watson KD, Hyrich KL, Noyce PR, Symmons DPM. 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. International Society of Pharmacoepidemiology (ISPE). Denmark: Copenhagen, Aug 17 – 20, 2008. Pharmacoepidemiology and Drug Safety 2008; 17(1): S192.External link
Systematic review examining the prevalence and nature of prescribing errors in hospital inpatients. Lewis P, Bell K, Dornan T, Taylor D, Tully MP, Ashcroft D. 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. International Society of Pharmacoepidemiology (ISPE). Denmark: Copenhagen, Aug 17 – 20, 2008. Pharmacoepidemiology and Drug Safety 2008; 17(1): S7.External link
Equity of community pharmacy distribution in England between 2004 and 2006. Wagner AC, Hann M, Ashcroft DM Institute for Health Research Service Delivery and Organisation Programme and Health Services Research Network conference. June 2008. Manchester.
Hospital admissions associated with non-compliance to medications: a systematic review of prospective observational studies. Kongkaew C, Noyce PR, Ashcroft DM. Institute for Health Research Service Delivery and Organisation Programme and Health Services Research Network conference. June 2008. Manchester.
Hospital admissions associated with adverse drug events: A systematic review of prospective observational studies Kongkaew C, Noyce PR, Ashcroft DM. Drug Utilisation Research Group (UK & Ireland) Conference 2008, London.
Influence of population characteristics on prescribing of hypnotics and anxiolytics in general practice Wagner AC, Ashworth M, Ashcroft DM. Drug Utilisation Research Group (UK & Ireland) Conference 2008, London.
Efficacy and safety of anti-TNF agents in psoriatic arthritis: Results from the BSR biologics register. Saad, A.; Ashcroft, DM; Watson, K.D. ; Hyrich, K.L.; Noyce, PR; Symmons, D. Rheumatology. 2008. 47:ii; 80-81.

2007

 

Patient preferences for drug treatments for psoriasis: A discrete choice experiment. Ashcroft DM, Seston E, Griffiths CEM. USA: Pittsburgh, 20-24th October 2007.
The Manchester Patient Safety Framework (MaPSaF). Parker D, Kirk S, Claridge T, Lawrie M, Ashcroft D. Patient Safety Research: shaping the European agenda - Conference proceedings: 112. Portugal: Porto, 24-26th September 2007.
Judgements on rule-related behaviour in community pharmacy. Ashcroft DM, Parker D, Morecroft C, Noyce PR. Patient Safety Research: shaping the European agenda - Conference proceedings: 011. Portugal: Porto, 24-26th September 2007.
Understanding procedural violations in the community pharmacy setting: A focus group study. Ashcroft DM, Morecroft C, Parker D, Noyce PR Patient Safety Research: shaping the European agenda – Conference proceedings: 010. Portugal: Porto, 24-26th September 2007
Measuring safety climate in the community pharmacy setting: Findings from a national cross-sectional survey. Ashcroft DM, Archer J, Parker D. Patient Safety Research: shaping the European agenda – Conference proceedings: 009. Portugal: Porto, 24-26th September 2007
Exploring the domains of professionalism in pharmacy education: a nominal group study Hall J, Ashcroft D. International Journal of Pharmacy Practice 2007; 15 (suppl 2): B10-B11
Immunosuppressive drugs: what do kidney transplant patients think about the risks and benefits? Widmann JD, Noyce PR, Parrott NR, Ashcroft DM. International Journal of Pharmacy Practice 2007; 15 (suppl 2): B17-B18
Implementing clinical governance under the new contract for community pharmacy: approaches, successes and challenges. Elvey R, Bradley F, Ashcroft DM, Noyce P. International Journal of Pharmacy Practice 2007; 15 (suppl 2): B22-B23.
Delivering enhanced community pharmacy services: qualitative insights into the process of innovation. Bradley F, Elvey R, Ashcroft DM, Noyce P. International Journal of Pharmacy Practice 2007; 15 (suppl 2): B23-B24.
How can community pharmacies provide quality of care? The patient and carer perspective Halsall D, Ashcroft DM, Noyce PR. International Journal of Pharmacy Practice 2007; 15 (suppl 2): B56-B57.
Use of a new patient-completed questionnaire to assess the communication skills of pharmacy students. Mackellar A, Bell D, Ashcroft D. International Journal of Pharmacy Practice 2007; 15 (suppl 2): B60.
Influence of disease-related factors on BMD in men and women with juvenile idiopathic arthritis (JIA). Thornton J, Pye S, Foster H, Rawlings D, Francis RM, Kumar N, Myers A, Symmons DPM, Ashcroft DM, O’Neill TW. Rheumatology 2007; 46: i25.
Meta-analysis of the efficacy and safety of TNF-a inhibitors in the management of psoriatic arthritis. Saad AA, Ashcroft DM, Symmons DPM, Noyce PR. Rheumatology 2007; 46: i49.
The cost of juvenile idiopathic arthritis (JIA): obtaining patient-based costs during the first year of diagnosis. Thornton J, Elliott RA, Lunt M, Ashcroft DM, Baildam E, Foster H, Davidson J, Gardner-Medwin J, Beresford M, Symmons D, Thomson W. Rheumatology 2007; 46: i106.

2006

 

Is community pharmacy becoming a sexual health resource? Findings from a national survey of primary care trust commissioners. Bradley F, Elvey R, Ashcroft D, Noyce P International Journal of Pharmacy Practice 2006; 14 (suppl 2): B119-B120
NHS enhanced pharmaceutical services: national survey of primary care trusts. Bradley F, Elvey R, Ashcroft D, Noyce P International Journal of Pharmacy Practice 2006; 14 (suppl 2): B111-B112
Patient safety culture: what do hospital pharmacy staff think? Cormack M, Mohammed S, Ashcroft DM, Williams SD International Journal of Pharmacy Practice 2006; 14 (suppl 2): B90-B91
Commissioning substance misuse services from community pharmacy. Bradley F, Elvey R, Ashcroft D, Noyce P International Journal of Pharmacy Practice 2006; 14 (suppl 2): B86-B87
Risk-benefit of new biologicals in the treatment of chronic plaque psoriasis. Saad AA, Ashcroft DM, Griffiths CEM, Noyce PR International Journal of Pharmacy Practice 2006; 14 (suppl 2): B60-B61
Criteria for the assessment of pharmacy students’ communication skills with patients: a Delphi consultation study. Mackellar A, Ashcroft DM, Bell D, James D, Marriott J International Journal of Pharmacy Practice 2006; 14 (suppl 2): B36-B37
Implementing medication usage reviews through the new community pharmacy contract: key drivers and barriers. Elvey R, Bradley F, Ashcroft D, Noyce P International Journal of Pharmacy Practice 2006; 14 (suppl 2): B32-B33
Medication errors: how reliable are the severity ratings reported to the National Reporting and Learning System? Newport A, Ashcroft DM, Williams SD International Journal of Pharmacy Practice 2006; 14 (suppl 2): B18-B19
Interventions for vitiligo: a Cochrane systematic review. Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U British Journal of Dermatology 2006; 155 (Suppl 1): 41
Systematic review of effectiveness and safety of bisphosphonates in the treatment of children with juvenile idiopathic arthritis and osteoporosis. Thornton J, Ashcroft DM, Elliott R, O’Neill TW, Symmons D Rheumatology 2006; 45: i115-i116
Pharmacovigilance and the role of meta-analysis: Risk of myocardial infarction associated with selective Cox-2 inhibitors. Chen L, Ashcroft DM 12th Health Services Research & Pharmacy Practice Conference - Proceedings. University of Bath, 2006; 44.
Hospital admissions associated with adverse drug reactions: A meta-analysis of prospective observational studies. Kongkaew C, Ashcroft DM, Noyce PR 12th Health Services Research & Pharmacy Practice Conference - Proceedings. University of Bath, 2006; 53.
Skill mix in community pharmacy: Observing the impact of repeat dispensing. Elvey R, Ashcroft DM, Morecroft C, Noyce P 12th Health Services Research & Pharmacy Practice Conference - Proceedings. University of Bath, 2006; 32.
Influence of prescription charges on repeat prescribing in primary care. Bradley F, Elvey R, Ashcroft DM, Noyce P 12th Health Services Research & Pharmacy Practice Conference - Proceedings. University of Bath, 2006; 25.
Repeat dispensing at pathfinder pilots: the general practice perspective. Elvey R, Ashcroft D, Noyce P 17th Annual Scientific Meeting of the Drug Utilisation Research Group (DURG). Pharmacoepidimiology and Drug Safety. 2006;15: 284-285.

2005

 

Developing community pharmacy services: change management issues. Elvey R, Ashcroft D, Bradley F, Hassell K, Kendall J, Sibbald B, Noyce P 8th Annual Conference of the Federation of Primary Care Research Organisations. Bristol: University of Bristol 28-29th November 2005.
Systematic review of effectiveness and safety of bisphosphonates in the treatment of children with juvenile idiopathic arthritis and osteoporosis. Thornton J, Ashcroft DM, Symmons D North West Rheumatology Meeting. Manchester , 2005.
Community pharmacists’ experiences of implementing a repeat dispensing service: a qualitative study. Morecroft CW, Ashcroft DM, Noyce P International Journal of Pharmacy Practice 2005; 13 (suppl): R35
Drivers and barriers to the implementation of repeat dispensing: qualitative insights from pathfinder PCTs. Morecroft CW, Ashcroft DM, Noyce P International Journal of Pharmacy Practice 2005; 13 (suppl): R34
Experimental study examining the reliability and likelihood of reporting medication errors in secondary care. Bentham L, Ashcroft DM, Williams S International Journal of Pharmacy Practice 2005; 13 (suppl): R30
Processes and consequences in local pharmaceutical needs assessments: experiences of local pharmaceutical services pilots. Elvey R, Kendall J, Bradley F, Ashcroft D, Hassell K, Sibbald B, Noyce P International Journal of Pharmacy Practice 2005; 13 (suppl): R11
Impact of enhanced service provision on community pharmacy: a longitudinal study of local pharmaceutical services pilots. Bradley F, Kendall J, Elvey R, Ashcroft D, Hassell K, Sibbald B, Noyce P International Journal of Pharmacy Practice 2005; 13 (suppl): R8
Regional inequalities in prescribing rates for upper respiratory tract infections - a survey using the General Practice Research Database. Smith S, Smith GE, Heatlie H, Bashford J, Ashcroft D, Verlander NQ, Duckworth GJ, Mason B, Smyth B, Maxwell S Health Protection Agency Annual Conference - Proceedings. Warwick 2005, p38.
Do economic evaluations have a role in decision-making in medicine management committees? A qualitative study. Chen L, Ashcroft DM, Elliott RA 11th Health Services Research & Pharmacy Practice Conference - Proceedings. Reading, 2005; 4.
Repeat dispensing in community pharmacy: a systematic review of the published literature. Morecroft C, Ashcroft D, Noyce P 11th Health Services Research & Pharmacy Practice Conference - Proceedings. Reading, 2005; 22.
Integrated working between community pharmacists and general practitioners: the experience of Local Pharmaceutical Services pilots. Bradley F, Kendall J, Ashcroft D, Elvey R, Hassell K, Noyce P, Sibbald B 11th Health Services Research & Pharmacy Practice Conference - Proceedings. Reading, 2005; 23.
Using the Local Pharmaceutical Services contract to enable community pharmacy to contribute to the provision of out of hours services. Elvey R, Kendall J, Sibbald B, Ashcroft D, Bradley F, Hassell K, Noyce P 11th Health Services Research & Pharmacy Practice Conference - Proceedings. Reading, 2005; 30.
Likelihood of reporting patient safety incidents: the case of community pharmacy. Ashcroft DM, Morecroft C, Parker D, Noyce P 11th Health Services Research & Pharmacy Practice Conference - Proceedings. Reading, 2005; 38.
Patient safety in community pharmacy. Ashcroft DM Invited presentation at “Risk Management: A challenge for Health Research”, 10th Anniversary Conference, CEFAR (Centro de Estudos de Farmacoepidemiologia). Lisbon, 24-26th February 2005.

2004

 

Using a case study methodology in evaluation research. Elvey R, Ashcroft D, Bradley F, Hassell K, Kendall J, Noyce P, Sibbald B 10th Evaluation Society (UKES) Conference: Enhancing and Improving Evaluation Practice - Proceedings. Glasgow, 6-8th December 2004.
Local Pharmaceutical Services medication review services: from paper to practice. Bradley F, Kendall J, Elvey R, Sibbald B, Ashcroft D, Hassell K, Noyce P International Journal of Pharmacy Practice 2004; 12 (suppl): R94
Judgements on the use of protocols by community pharmacists: an experimental study with pharmacy students. Ashcroft DM, Morecroft C, Mamun S International Journal of Pharmacy Practice 2004; 12 (suppl): R55
Likelihood of reporting incidents in community pharmacy: pharmacy students’ perspectives. Ashcroft DM, Morecroft C, Lowe J International Journal of Pharmacy Practice 2004; 12 (suppl): R54
Controlled trial of a pharmacist-led surgical pre-admission clinic in secondary care. Spiller C, Ashcroft DM International Journal of Pharmacy Practice 2004; 12 (suppl): R31
Cost-effectiveness analysis of selective cyclo-oxygenase-2 inhibitors in preventing drug-induced adverse gastrointestinal bleeding following major orthopaedic surgery. Chen L, Elliott RA, Ashcroft DM International Journal of Pharmacy Practice 2004; 12 (suppl): R26
Reporting, reflecting and learning from incidents in community pharmacy: development and validation of an incident reporting form Morecroft C, Ashcroft D, Parker D, Noyce P, Cantrill J International Journal of Pharmacy Practice 2004; 12 (suppl): R12
Pimecrolimus and tacrolimus for atopic eczema: a systematic review and cost-utility analysis. Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P 1st Annual Meeting, Health Technology Assessment International (HTAi): Krakow, 2004.
Innovation in community pharmacy contracts: describing first wave local pharmaceutical services (LPS) pilots. Kendall J, Sibbald B, Ashcroft D, Hassell K, Noyce P 10th Health Services Research & Pharmacy Practice Conference - Proceedings. London, 2004; 51.
Systematic review of the analgesic efficacy and tolerability of Cox-2 inhibitors in postoperative pain control Chen LC, Elliott R, Ashcroft D 10th Health Services Research & Pharmacy Practice Conference - Proceedings. London, 2004; 21.